Assenagon Asset Management
IMMU

Assenagon Asset Management’s Immunomedics Inc IMMU Stock Holding History

Assenagon Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-353,308
Closed -$30M – 1341
2020
Q3 		$30M Sell
353,308
-648,510
-65% -$32.8M 0.17% 97
2020
Q2 		$35.5M Buy
+1,001,818
New +$29.3M 0.23% 78

Assenagon Asset Management's IMMU Position: Q4 2020 in Review

Assenagon Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 353,308 shares — an estimated $30M sold.

Assenagon Asset Management first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $35.5M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Assenagon Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Assenagon Asset Management sold 353,308 Immunomedics Inc shares in Q4 2020, an estimated $30M.
  • Assenagon Asset Management first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Assenagon Asset Management's Immunomedics Inc position peaked at $35.5M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Assenagon Asset Management's 13F filing for Q4 2020, filed 1 Feb 2021.